Stock listing
Munich:LFC0 Lifecare ASA Aktie
German listing (Munich) of Lifecare ASA · home listing Oslo:LIFE
Follow Lifecare ASA into a list and get an email when it puts out news.
Home listing price · OSL:LIFE
0.345 NOK -0.031 (-8.1%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OSL:LIFE
- Day range
- 0.310 – 0.361 NOKNov 20, 2026
- Volume
- 3.69M sharesNov 20, 2026
- Market cap
- 148.3M NOKAt the close on Nov 20, 2026 · price × 430.4M shares outstanding
- 52-week range
- 0.270 – 5.860 NOKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 4.51M NOKMedian day 2.36M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Oslo:LIFE · Home | 0.345 NOK | -0.031 (-8.1%) | 3,692,967 | 0.361 | 0.361 | 0.310 | 0.375 | Close on Nov 20, 2026 |
| Frankfurt:LFC0 | €0.031 EUR | 0.000 (-1.0%) | — | €0.031 | €0.031 | €0.031 | €0.031 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OSL:LIFE · NOK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 0.345 | -0.031 | -8.1% | 0.361 | 0.361 | 0.310 | 3,692,967 | |
| 0.375 | +0.025 | +7.0% | 0.350 | 0.380 | 0.338 | 1,609,856 | |
| 0.351 | -0.020 | -5.3% | 0.375 | 0.375 | 0.350 | 2,152,366 | |
| 0.370 | -0.011 | -2.8% | 0.387 | 0.387 | 0.361 | 2,807,349 | |
| 0.381 | -0.007 | -1.7% | 0.382 | 0.390 | 0.376 | 2,057,911 | |
| 0.387 | -0.028 | -6.9% | 0.410 | 0.416 | 0.382 | 4,435,721 | |
| 0.416 | +0.032 | +8.5% | 0.410 | 0.420 | 0.385 | 2,785,964 | |
| 0.383 | -0.015 | -3.8% | 0.410 | 0.410 | 0.382 | 2,225,854 | |
| 0.398 | -0.008 | -2.1% | 0.410 | 0.410 | 0.394 | 2,908,348 | |
| 0.407 | -0.013 | -3.0% | 0.410 | 0.415 | 0.404 | 3,145,053 | |
| 0.419 | -0.002 | -0.4% | 0.420 | 0.431 | 0.413 | 1,874,026 | |
| 0.421 | +0.002 | +0.4% | 0.419 | 0.439 | 0.414 | 2,237,108 | |
| 0.419 | -0.003 | -0.6% | 0.440 | 0.440 | 0.416 | 1,680,524 | |
| 0.422 | -0.015 | -3.3% | 0.435 | 0.456 | 0.418 | 4,519,408 | |
| 0.436 | +0.009 | +2.1% | 0.434 | 0.480 | 0.428 | 5,445,290 | |
| 0.427 | +0.024 | +6.0% | 0.403 | 0.434 | 0.403 | 5,474,092 | |
| 0.403 | -0.017 | -4.2% | 0.426 | 0.426 | 0.398 | 4,319,528 | |
| 0.421 | -0.033 | -7.2% | 0.455 | 0.455 | 0.410 | 6,365,415 | |
| 0.453 | +0.077 | +20.5% | 0.450 | 0.529 | 0.414 | 23,216,149 | |
| 0.376 | -0.009 | -2.3% | 0.409 | 0.409 | 0.376 | 2,867,273 | |
| 0.385 | -0.035 | -8.3% | 0.420 | 0.420 | 0.384 | 4,488,073 | |
| 0.420 | -0.004 | -0.9% | 0.424 | 0.429 | 0.410 | 3,166,309 | |
| 0.424 | +0.004 | +1.0% | 0.430 | 0.430 | 0.410 | 2,319,610 | |
| 0.420 | +0.019 | +4.9% | 0.406 | 0.450 | 0.403 | 7,746,470 | |
| 0.401 | -0.009 | -2.3% | 0.410 | 0.419 | 0.392 | 4,715,761 | |
| 0.410 | -0.011 | -2.6% | 0.420 | 0.420 | 0.410 | 4,304,708 | |
| 0.421 | -0.023 | -5.2% | 0.440 | 0.455 | 0.420 | 6,932,596 | |
| 0.444 | +0.025 | +5.8% | 0.425 | 0.480 | 0.420 | 8,804,207 | |
| 0.420 | +0.011 | +2.6% | 0.414 | 0.430 | 0.392 | 3,711,867 | |
| 0.409 | +0.003 | +0.6% | 0.390 | 0.414 | 0.386 | 6,426,313 | |
| 0.407 | -0.023 | -5.4% | 0.440 | 0.440 | 0.400 | 7,440,809 | |
| 0.430 | -0.001 | -0.1% | 0.440 | 0.490 | 0.425 | 12,521,389 | |
| 0.430 | -0.031 | -6.7% | 0.469 | 0.469 | 0.416 | 15,410,774 | |
| 0.461 | -0.020 | -4.2% | 0.553 | 0.560 | 0.460 | 16,454,645 | |
| 0.481 | +0.021 | +4.6% | 0.478 | 0.539 | 0.452 | 39,956,184 | |
| 0.460 | -0.110 | -19.3% | 0.565 | 0.640 | 0.442 | 71,625,172 | |
| 0.570 | +0.018 | +3.3% | 0.580 | 0.838 | 0.538 | 157,229,547 | |
| 0.552 | +0.260 | +88.7% | 0.331 | 0.552 | 0.326 | 114,287,422 | |
| 0.293 | -0.007 | -2.3% | 0.300 | 0.300 | 0.288 | 1,750,358 | |
| 0.300 | +0.004 | +1.4% | 0.300 | 0.300 | 0.290 | 2,504,486 | |
| 0.296 | -0.005 | -1.5% | 0.315 | 0.315 | 0.290 | 788,204 | |
| 0.300 | 0.000 | 0.0% | 0.300 | 0.320 | 0.288 | 1,985,936 | |
| 0.300 | -0.009 | -2.8% | 0.309 | 0.310 | 0.291 | 1,813,353 | |
| 0.309 | -0.012 | -3.6% | 0.320 | 0.320 | 0.307 | 771,360 | |
| 0.320 | -0.015 | -4.5% | 0.335 | 0.345 | 0.311 | 2,398,504 | |
| 0.335 | +0.048 | +16.5% | 0.288 | 0.345 | 0.283 | 6,798,341 | |
| 0.288 | -0.001 | -0.2% | 0.290 | 0.290 | 0.283 | 1,082,342 | |
| 0.288 | +0.005 | +1.6% | 0.290 | 0.290 | 0.284 | 751,397 | |
| 0.284 | +0.001 | +0.2% | 0.290 | 0.290 | 0.283 | 593,536 | |
| 0.283 | +0.002 | +0.5% | 0.283 | 0.290 | 0.283 | 1,323,158 | |
| 0.282 | -0.004 | -1.2% | 0.290 | 0.290 | 0.280 | 1,049,070 | |
| 0.285 | -0.005 | -1.7% | 0.284 | 0.287 | 0.283 | 346,900 | |
| 0.290 | +0.009 | +3.0% | 0.290 | 0.291 | 0.282 | 1,241,485 | |
| 0.282 | -0.004 | -1.4% | 0.294 | 0.294 | 0.282 | 893,517 | |
| 0.286 | -0.003 | -1.0% | 0.290 | 0.290 | 0.281 | 518,885 | |
| 0.289 | -0.002 | -0.5% | 0.290 | 0.290 | 0.286 | 668,744 | |
| 0.290 | +0.003 | +0.9% | 0.282 | 0.290 | 0.280 | 629,465 | |
| 0.288 | -0.002 | -0.7% | 0.295 | 0.295 | 0.282 | 1,569,545 | |
| 0.290 | +0.002 | +0.5% | 0.286 | 0.295 | 0.284 | 1,662,487 | |
| 0.288 | -0.002 | -0.7% | 0.285 | 0.291 | 0.283 | 2,094,013 | |
| 0.290 | +0.003 | +1.0% | 0.295 | 0.295 | 0.285 | 1,041,438 | |
| 0.287 | -0.008 | -2.7% | 0.292 | 0.292 | 0.285 | 1,735,595 | |
| 0.295 | -0.004 | -1.2% | 0.299 | 0.299 | 0.290 | 1,198,719 | |
| 0.299 | +0.007 | +2.2% | 0.308 | 0.308 | 0.281 | 1,615,152 | |
| 0.292 | +0.004 | +1.4% | 0.299 | 0.306 | 0.285 | 1,786,549 | |
| 0.288 | -0.017 | -5.6% | 0.320 | 0.320 | 0.288 | 2,173,636 |
Splits
2 splits since 2019 · OSL:LIFE · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-13 | Consolidation | |
| 1-for-4 | Consolidation |
- Ticker
- Munich:LFC0
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news release · Jun 12, 2026
Lifecare ASA: Final results following expiry of exercise period for Warrants Series 2 issued in connection with Rights Issue
Latest news
Lifecare ASA: Final results following expiry of exercise period for Warrants Series 2 issued in connection with Rights Issue
Jun 12, 2026
Closed 0.31 (+6.9%) on Jun 15, 2026
Lifecare ASA: Mandatory notification of trade
Jun 10, 2026
Closed 0.30 (-9.1%) on Jun 11, 2026
Lifecare ASA on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 3 in the last 12 months · 3 in all · newest Jun 12, 2026 · oldest 2026
- Decks
- 10 decks · latest November 2025
Where Lifecare ASA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Oslo:LIFE · Home listing | Oslo | Norway | NOK |
| Stockholm:LIFEO | Stockholm | Sweden | NOK |
| Lang & Schwarz:A40P11 | Lang & Schwarz | Germany | EUR |
| gettex:LFC0 | gettex | Germany | EUR |
| LS Exchange:A40P11 | LS Exchange | Germany | EUR |
| Frankfurt:LFC0 | Frankfurt | Germany | EUR |
| Stuttgart:LFC0 | Stuttgart | Germany | EUR |
| Dusseldorf:LFC0 | Dusseldorf | Germany | EUR |
| Munich:LFC0 · This page | Munich | Germany | EUR |
Valuation
EV/sales 175× against a median of 1.2×: the highest of 9 Medical devices & supplies companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- 111.4M NOK
- P/E
- Loss
- EV/sales
- 175×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 2.7×
- Gross margin
- Revenue too small
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Lifecare ASA · OSL:LIFE | US$15.21M | US$11.43M | n/a | 175× | n/a | 2.7× | n/a | 0.0× | n/a |
| Modular Medical, Inc. · NASDAQ:MODD | US$16.36M | US$11.26M | n/a | n/a | n/a | 1.4× | n/a | 0.0× | 2.27 |
| European Medical Solutions. · EURONEXT:ALEMS | US$16.25M | US$33.71M | 8.1× | 0.6× | 6.3× | 1.1× | 3.7% | 1.5× | n/a |
| Picard Medical, Inc. · AMEX:PMI | US$15.88M | US$17.30M | n/a | 3.3× | n/a | 11.9× | −371.7% | 1.1× | 0.41 |
| SG Healthcare Co., Ltd. · KRX:398120 | US$15.78M | US$11.93M | 19.3× | 0.6× | n/a | 0.9× | 4.2% | 0.0× | n/a |
| Careplus Group Bhd. · MYX:CAREPLS | US$15.50M | US$20.64M | n/a | 0.8× | n/a | 0.3× | −11.1% | 0.1× | n/a |
| HeartBeam, Inc. · NASDAQ:BEAT | US$15.50M | US$9.44M | n/a | n/a | n/a | 2.4× | n/a | 0.0× | 1.93 |
| Control Bionics Ltd. · ASX:CBL | US$15.13M | US$14.16M | n/a | 4.5× | n/a | 3.6× | −152.4% | 0.1× | n/a |
| Micro-X Ltd. · ASX:MX1 | US$14.45M | US$16.66M | n/a | 1.7× | n/a | 4.5× | −65.5% | 1.3× | n/a |
| Perimeter Medical Imaging AI Inc · TSXV:PINK | US$14.45M | US$8.00M | n/a | 3.8× | n/a | 3.5× | −478.7% | 0.0× | 1.55 |
| CVRx, Inc. · NASDAQ:CVRX | US$14.27M | US$14.18M | n/a | 0.2× | n/a | 1.0× | −88.3% | 4.2× | 1.28 |
| Median of the others | US$15.50M | US$14.17M | 13.7× | 1.2× | 6.3× | 1.9× | −76.9% | 0.1× | 1.55 |
Forecasts
Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.
- Price target
- 0.35 NOK · Analysts' mean
- EPS, year to Dec 2026
- -0.27 · 1 analyst
- Revenue, year to Dec 2026
- 1M · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Joacim Holter | Chief Executive Officer |
| Petter Nielsen | Chief Financial Officer |
Board
| Director | Role |
|---|---|
| Hans Johan Hekland | Member of the Board & member of the Audit Committee |
| Kathrine Gamborg Andreassen | Member of the Board |
| Morten Foros Krohnstad | Chair of the Board & Chair of the Remuneration Committee |
| Renate Kaarvik | Member of the Board & Chair of the Audit Committee |
| Renete Kaarvik | Member of the Board & Chair of the Audit Committee |
| Tore Birger Ellingsen | Member of the Board |
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2026 | Nov 13, 2026 | −4.4% |
| Q2 2026 | Aug 19, 2026 | −9.2% |
| Q1 2026 | May 18, 2026 | −1.6% |
| Q4 2025 | Mar 4, 2026 | +3.2% |
| Q3 2025 | Nov 13, 2025 | +2.1% |
| Q2 2025 | Aug 20, 2025 | −31.0% |
| Q1 2025 | May 15, 2025 · Before open | −1.2% |
| Q4 2024 | Feb 20, 2025 · Before open | −12.0% |
| Q3 2024 | Nov 13, 2024 · Before open | −4.8% |
| Q2 2024 | Aug 27, 2024 · Before open | +5.9% |
All 15 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 8, 2024 · Before open | −5.3% |
| Q4 2023 | Feb 27, 2024 · Before open | −4.9% |
| Q3 2023 | Nov 14, 2023 · Before open | −7.6% |
| Q2 2023 | Aug 23, 2023 · Before open | −2.6% |
| Q1 2023 | May 31, 2023 | −4.3% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (November 2025) | Investor deck | 21 slides | November 2025 |
| Q2 2025 Earnings Presentation | Earnings | 25 slides | August 2025 |
| Investor Presentation (April 2025) | Investor deck | 21 slides | April 2025 |
| Investor Presentation (March 2025) | Investor deck | 20 slides | March 2025 |
| Investor Presentation (October 2024) | Investor deck | 21 slides | October 2024 |
| Investor Presentation (October 2024) | Investor deck | 20 slides | October 2024 |
| Redeye Lifecare presentation (September 2023) | Conference | 29 slides | Sep 26, 2023 |
| Investor Presentation (June 2022) | Investor deck | 29 slides | June 2022 |
| FY2021 Earnings Presentation | Earnings | 17 slides | Apr 21, 2022 |
| Investor Presentation (September 2021) | Investor deck | 25 slides | Sep 21, 2021 |
Financings
| Raise | Date |
|---|---|
| Warrant exercise of warrants Series 2 exercised for new shares Announced: NOK 0.249 a share | Jun 12, 2026 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in NOK
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 112.0K | 2.48M | 4.26M | 16.7M | 324.4K | 1.67M | 2.07M | 3.49M | 551.1K | 1.61M |
| Cost of revenue | 1.53M | 29.0M | 16.8M | 7.25M | 8.51M | 12.0M | 1.50M | 2.35M | ||
| Gross profit | 3.03M | 11.6M | -12.3M | -16.5M | -5.58M | -6.44M | -8.53M | -945.0K | -738.6K | |
| Research and development | 67.9M | 19.4M | 2.60M | 9.40M | 7.90M | 6.30M | 6.90M | |||
| Selling, general and administrative | 15.6M | 15.7M | 8.08M | |||||||
| Operating income | -130.0M | -84.8M | -35.3M | -16.9M | -15.9M | -2.46M | -6.74M | -8.73M | -3.42M | -4.98M |
| Depreciation and amortization | 8.00M | 4.92M | 3.25M | 2.75M | 598.1K | 19.0K | 19.0K | 19.0K | 19.0K | 26.8K |
| EBITDA | -122.0M | -79.9M | -32.1M | -14.2M | -15.3M | -2.44M | -6.72M | -8.71M | -3.40M | -4.96M |
| Interest expense | 4.99M | 892.0K | 980.0K | 637 | 4.22K | 425 | 361 | 63.7K | 2.16K | 56.9K |
| Income before tax | -120.8M | -73.5M | -35.3M | -16.7M | -16.0M | -2.61M | -6.55M | -8.79M | -3.43M | -4.99M |
| Income tax | -561.0K | -740.0K | -116.0K | 527.2K | -102.6K | 132.9K | 361 | 1.07K | -11.3K | 45.0K |
| Net income | -119.5M | -71.8M | -35.3M | -17.5M | -15.9M | -2.74M | -6.56M | -8.79M | -3.43M | -4.99M |
| Earnings per share, basic | -6.80 | -5.73 | -3.81 | -1.48 | -1.77 | -0.30 | -0.81 | -1.09 | -0.62 | -0.90 |
| Earnings per share, diluted | -6.80 | -5.73 | -3.81 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 5.65M | 61.6M | 48.3M | 47.6M | 21.0M | 11.5M | 14.6M | 21.3M | 2.49K | 139.3K |
| Short-term investments | 10.6M | |||||||||
| Receivables | 78.0K | 2.20M | 4.02M | 4.42M | 2.43M | 74.9K | 2.55M | 1.84M | 908.5K | 1.50M |
| Inventory | -2.72M | 1 | 1 | 1 | -908.5K | -1.50M | ||||
| Current assets | 21.7M | 74.8M | 64.0M | 54.8M | 23.5M | 14.4M | 17.1M | 23.2M | 910.9K | 1.64M |
| Property, plant and equipment | 18.2M | 14.5M | 3.19M | 2.99M | 29.7K | |||||
| Goodwill | 7.23M | 7.23M | 7.23M | 5.98M | 1.54M | |||||
| Total assets | 95.0M | 112.6M | 86.4M | 70.0M | 32.2M | 14.6M | 17.5M | 23.4M | 1.19M | 1.86M |
| Accounts payable | 19.7M | 5.67M | 3.59M | 1.63M | 1.97M | 458.5K | 731.0K | 831.6K | 626.7K | 118.6K |
| Current liabilities | 83.8M | 29.4M | 10.6M | 9.89M | 3.74M | 1.28M | 1.76M | 1.18M | 3.54M | 1.01M |
| Long-term debt | 2.92M | 4.35M | 2.70M | 0 | ||||||
| Total debt | 51.7M | 0 | 9.37M | 8.29M | 2.70M | 2.27M | 245.0K | |||
| Total liabilities | 123.1M | 38.6M | 19.9M | 14.7M | 7.98M | 1.28M | 1.76M | 1.18M | 3.54M | 1.01M |
| Shareholders' equity | -28.0M | 74.0M | 66.5M | 56.4M | 24.2M | 13.3M | 15.7M | 22.2M | -2.35M | 848.5K |
| Shares outstanding | 54.7M | 12.8M | 9.26M | 11.8M | 8.99M | 8.99M | 8.09M | 8.09M | 5.53M | 5.53M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -110.4M | -65.5M | -37.3M | -17.8M | -13.8M | -2.80M | -6.70M | -6.70M | -6.70M | |
| Capital spending | -6.46M | -12.8M | -1.22M | -5.71M | -7.49M | -7.49M | -7.49M | -7.49M | 0 | 0 |
| Free cash flow | -116.8M | -78.3M | -38.5M | -23.6M | -21.3M | -2.80M | 38.0K | -14.2M | -6.70M | |
| Cash from investing | -6.46M | -12.4M | -1.22M | -9.20M | -6.94M | -246.9K | -1.74M | -1.74M | -1.74M | |
| Cash from financing | 60.9M | 91.2M | 39.3M | 53.6M | 30.3M | -62.8K | 724.9K | 724.9K | 724.9K | |
| Change in cash | -56.0M | 13.3M | 715.0K | 26.6M | 9.57M | -3.11M | -6.74M | -7.72M | -7.72M |
Cap table
Built by 6ix from Lifecare ASA’s releases · as of Jun 12, 2026
- Common shares
- 430,360,937
- Fully diluted
- 430,360,937
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 430,360,937 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 430,360,937 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Hans Johan Hekland | Member of the Board & member of the Audit Committee · Since at least Nov 5, 2026 |
| Joacim Holter | Chief Executive Officer · Since at least Jun 12, 2026 |
| Kathrine Gamborg Andreassen | Member of the Board · Since at least Nov 5, 2026 |
| Morten Foros Krohnstad | Chair of the Board & Chair of the Remuneration Committee · Since at least Jun 10, 2026 |
| Petter Nielsen | Chief Financial Officer · Since at least Jun 12, 2026 |
| Renate Kaarvik | Member of the Board & Chair of the Audit Committee · Since at least Nov 4, 2026 |
| Renete Kaarvik | Member of the Board & Chair of the Audit Committee · Since at least Nov 5, 2026 |
| Tore Birger Ellingsen | Member of the Board · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Lifecare ASA.